Can a Heart CT Scan Detect Blocked Arteries?

Coronary CT angiography can detect blocked arteries with high accuracy and has become a frontline tool for evaluating chest pain in many hospitals worldwide. Studies consistently show the technique catches significant blockages with sensitivity in the range of 80 to 95 percent, depending on the degree of narrowing and the patient population, while its ability to rule out disease is even stronger. But the scan does more than just find blockages, and the story of what it can and cannot tell you about your heart is worth understanding in detail.

How the Scan Actually Works

A coronary CT angiography (often called CCTA) uses a fast CT scanner synchronized to your heartbeat. An iodine-based contrast dye is injected through an IV in your arm, and as it flows through your coronary arteries, the scanner captures cross-sectional images in a matter of seconds. Software then reconstructs those images into a detailed three-dimensional map of the arteries that supply blood to your heart muscle. The entire scan portion typically takes under ten seconds of actual imaging time, though preparation and recovery stretch the visit to roughly 30 to 60 minutes.

There is also a simpler, older type of heart CT called a coronary artery calcium score (CACS), which does not use contrast dye at all. Instead of looking at the blood flowing through your arteries, it measures how much calcium has built up in the artery walls. Calcium deposits are a marker of atherosclerosis, so a high score signals that plaque is present, but the calcium score alone cannot tell you how much a given artery is narrowed or whether blood flow is actually restricted. The two scans serve different purposes, and understanding that distinction matters when your doctor orders one versus the other.

How Accurate Is It at Finding Blockages?

Accuracy numbers vary across studies because researchers use different scanners, patient groups, and thresholds for what counts as a significant blockage. One study of 99 patients found that CT coronary angiography had an overall sensitivity of about 87 percent and specificity of 98 percent when compared with traditional catheter-based angiography, with overall accuracy at roughly 97 percent.¹ A study using 128-slice dual-source CT in 40 patients reported sensitivity and specificity above 95 percent at the segment level.²

A more recent comparison from a larger patient group found that when the threshold was set at 70 percent or greater narrowing, CT angiography had a sensitivity of about 81 percent and a negative predictive value above 90 percent. When the threshold dropped to 50 percent narrowing, sensitivity climbed to about 94 percent.³ That pattern is consistent across the literature: CT angiography is better at catching moderate disease than severe disease, largely because heavily calcified plaques can obscure the true degree of narrowing on CT images.

Where CT really shines is in ruling disease out. The negative predictive value, meaning the chance that a normal-looking CT scan truly means you do not have significant blockages, consistently runs above 90 percent across studies. For patients whose risk of coronary artery disease is low to intermediate, a clean CT scan is extremely reassuring and typically means no further invasive testing is needed.⁴

What the Calcium Score Tells You on Its Own

If your doctor orders a calcium score rather than a full CT angiography, the goal is risk stratification rather than direct blockage detection. A calcium score of zero means no detectable calcified plaque, which is associated with a very low risk of a heart attack or other major cardiac event over the next several years. As the score rises, so does risk. A large study found that the three-year rate of major cardiac events was about 2 percent for a score of zero, roughly 13 percent for scores between 1 and 100, around 16 percent for scores of 101 to 400, and about 34 percent for scores above 400.⁵

The calcium score is particularly useful for people without symptoms who fall into the “intermediate risk” category based on traditional factors like age, cholesterol, and blood pressure. In that group, adding a calcium score to standard risk calculators substantially improves the ability to predict who will and who will not have a cardiovascular event, allowing more targeted use of preventive medications like statins.⁶ A systematic review confirmed that calcium scoring provides meaningful prognostic value beyond traditional risk scores, with particular benefit in reclassifying intermediate-risk individuals into clearer low-risk or high-risk categories.⁷

Beyond Blockages: Seeing the Plaque Itself

One of the most underappreciated strengths of coronary CT angiography is that it does not just show whether an artery is narrowed. It shows the plaque that is causing the narrowing, and the type of plaque matters. Calcified plaque is hard and relatively stable. Non-calcified or “soft” plaque, and mixed plaque containing both components, tend to be more dangerous because they are more likely to rupture and trigger a heart attack. Research on predicting cardiac events found that mixed plaques carried the highest risk, with a three-year major event rate of about 38 percent, compared with roughly 23 percent for non-calcified and about 6 percent for purely calcified plaques.⁵

Automated software can now measure the volume of non-calcified plaque from CT images with excellent correlation to intravascular ultrasound, which is the reference standard performed during catheterization.⁸ Researchers have also shown that low-density plaque on CT correlates with lipid-rich cores inside the artery wall, which are the features most closely linked to plaque rupture.⁹ This means a CT scan can sometimes flag arteries that look only mildly narrowed but contain the kind of plaque that is most prone to causing sudden events.

CT-Derived Fractional Flow Reserve

Finding a blockage is one thing. Knowing whether it actually starves the heart muscle of blood is another. A narrowing that looks like 60 percent on imaging might be hemodynamically insignificant in one person and clinically important in another, depending on factors like the length of the lesion, the size of the artery, and collateral blood supply. This is where CT-derived fractional flow reserve, or FFR-CT, comes in.

FFR-CT uses computational modeling to simulate blood flow through the coronary arteries based on the anatomy captured during a standard CT angiography scan. A value above 0.80 is considered normal, 0.76 to 0.80 is borderline, and 0.75 or lower suggests the blockage is restricting flow enough to warrant treatment.¹⁰ The advantage is that this functional information comes from the same CT dataset, with no additional scanning, no additional radiation, and no catheter. FFR-CT increases the specificity of CT angiography, meaning it helps avoid unnecessary invasive procedures by confirming that a blockage seen on the images is actually causing a problem.¹¹

How CT Compares to Invasive Catheterization

Traditional coronary angiography, performed through a catheter threaded into the heart from an artery in the wrist or groin, has been the gold standard for decades. It gives excellent images and allows treatment in the same session if a blockage needs a stent. But it carries real risks: arterial injury, bleeding, stroke, and allergic reactions to the contrast dye all occur at low but non-trivial rates.

The DISCHARGE trial, a large randomized study, directly compared a CT-first approach against going straight to invasive catheterization in patients with stable chest pain. Over about three and a half years, major cardiac events occurred in about 2 percent of the CT group and 3 percent of the invasive group, a difference that did not reach statistical significance. But major procedure-related complications were dramatically lower in the CT group: about 0.5 percent compared with roughly 2 percent in the catheterization group.¹² In practical terms, patients who start with CT have similar outcomes but with far fewer procedural complications, making it an attractive first step for most people with stable symptoms.

Long-Term Outcomes When CT Guides Treatment

The most compelling evidence for a CT-first strategy comes from the SCOT-HEART trial, which followed over 4,000 patients with stable chest pain for a decade. At 10 years, patients who had been randomized to receive CT angiography in addition to standard care experienced fewer heart attacks and fewer major adverse cardiovascular events than those managed with standard care alone. Non-fatal heart attacks were roughly 4.3 percent in the CT group versus 6.0 percent in the standard care group.¹³

The mechanism behind this benefit was not more stents or bypass surgeries. Revascularization rates were virtually identical between the two groups. Instead, patients who got a CT scan were more likely to be started on preventive medications, particularly statins and other lipid-lowering drugs, because the scan revealed atherosclerosis that might otherwise have gone undetected.¹⁴ Seeing plaque on a scan changes both physician behavior and patient motivation in ways that a normal stress test result simply does not.

Preparation and What to Expect

Getting good images from a coronary CT requires a slow, steady heartbeat. Most facilities aim for a heart rate of 60 beats per minute or lower during the scan. If your resting heart rate is higher than that, you will likely be given a beta-blocker medication beforehand. Some protocols have you take a long-acting beta-blocker pill the night before, which has been shown to meaningfully lower heart rate by the time you arrive the next morning.¹⁵ Others give an IV beta-blocker at the facility right before scanning.¹⁶ You may also be given nitroglycerin spray under your tongue to dilate the coronary arteries and make them easier to visualize.

You will need to avoid caffeine for several hours beforehand, since it raises heart rate. You will be asked to hold your breath for a few seconds during the actual scan. The contrast injection can cause a warm flushing sensation and a metallic taste in the mouth, both of which pass quickly. If you have asthma or a known allergy to iodinated contrast, you may be premedicated with steroids and antihistamines, or your doctor may choose a different test entirely.

Radiation and Contrast Dye Risks

Radiation exposure from a coronary CT scan has dropped sharply over the past decade. Modern techniques like prospective ECG-triggered acquisition, where the scanner only fires X-rays during a narrow window of the heartbeat, cut radiation dose by roughly a third compared with older approaches.¹⁷ A typical coronary CT angiography today delivers somewhere around 2 to 5 millisieverts with optimized protocols, comparable to one or two years of natural background radiation. A calcium score scan is even lower, often below 1 millisievert. For context, a diagnostic catheter-based coronary angiography usually delivers more.

The contrast dye poses a separate concern, primarily for your kidneys. Contrast-associated kidney injury is most likely in people who already have reduced kidney function or diabetes.¹⁸ The risk is considerably lower with the intravenous contrast used in CT compared with the intra-arterial contrast used in catheterization. One comparative study found a 6 percent incidence of contrast-induced kidney injury with IV contrast versus about 25 percent with intra-arterial delivery.¹⁹ For people with healthy kidneys, the risk of any meaningful kidney impact from a single CT scan is very low. Your doctor will typically check a blood creatinine level beforehand if there is any concern.

Known Limitations

CT angiography is not perfect, and certain situations make it less reliable. Heavy coronary calcification is the biggest technical challenge. Dense calcium deposits create a “blooming” artifact on the images, where the calcium appears larger than it actually is and can make a mild narrowing look severe, or obscure the true lumen entirely. Researchers continue to develop processing techniques to reduce this artifact, including specialized reconstruction algorithms, but it remains a limitation, particularly in older patients with extensive calcification.²⁰

Irregular heart rhythms, especially atrial fibrillation, can degrade image quality because the scanner relies on a predictable heartbeat to time its images. Obesity can reduce image quality due to increased noise. And patients who cannot hold their breath for a few seconds may end up with motion artifacts. Coronary stents, particularly small ones, are also difficult to evaluate on CT because the metal struts create their own artifacts, though newer scanners handle this better than older ones.

Another limitation worth knowing: a coronary CT angiography is focused on the heart, and most scans use a limited field of view. A study comparing limited and full fields of view found that over 67 percent of lung nodules larger than one centimeter and over 80 percent of smaller nodules were missed when only the limited cardiac field was reviewed.²¹ Many institutions now routinely reconstruct the full field of view to catch incidental findings, but it is worth asking whether yours does.

Cost Considerations

A coronary CT angiography typically costs less than invasive catheterization and far less than a hospital admission for observation and serial testing. Economic modeling studies have found that a CT-first approach, while sometimes associated with higher upfront costs than standard triage, tends to be cost-effective or even cost-saving over a lifetime because it leads to more appropriate use of preventive therapy and fewer downstream complications.²² A head-to-head comparison with nuclear stress testing (myocardial perfusion SPECT) found that a CT-based strategy was both less expensive per correct diagnosis and more effective in the long run.²³

In some health systems, particularly in the UK, chest pain clinics now use clinical risk scores to triage patients and bring intermediate-risk individuals back within days for a CT scan, avoiding hospital admission entirely.²⁴ This kind of streamlined pathway reduces costs, frees hospital beds, and gets patients an answer faster than the traditional admit-and-observe approach.

AI-Powered Plaque Analysis

One of the fastest-moving areas in cardiac CT is the application of artificial intelligence to plaque characterization. Over the past several years, AI tools have emerged that can automatically quantify how much plaque is in each coronary artery and classify it by type, all from a standard CT angiography dataset.²⁵ When validated against intravascular ultrasound, these AI-enabled tools show high agreement for total plaque volume and plaque composition.²⁶ A separate validation against optical coherence tomography, an even higher-resolution invasive imaging tool, found strong correlations for plaque volume with a correlation coefficient of 0.84.²⁷

What makes this clinically exciting is the potential to move beyond simple “blocked or not blocked” reporting. If AI can reliably identify patients who have a large burden of vulnerable, lipid-rich plaque before they have a heart attack, it opens the door to targeted prevention rather than waiting for an event. The research is still maturing, but the validation data so far are encouraging enough that several commercial platforms are already in clinical use.

Photon-Counting CT and the Next Generation of Scanners

The newest hardware development in cardiac CT is photon-counting detector technology, which represents the first fundamental change in how CT detectors work in decades. Conventional CT detectors convert X-rays into visible light and then into electrical signals, losing information at each step. Photon-counting detectors convert X-rays directly into electrical signals, which improves spatial resolution, reduces electronic noise, lowers radiation dose, and enables better material discrimination.²⁸

For coronary imaging specifically, photon-counting CT offers sharper visualization of coronary artery lumens, better assessment of stents, improved plaque characterization, and intrinsic spectral imaging capabilities that allow tissue differentiation without additional scan acquisitions.²⁹ The first commercial photon-counting CT scanners are already installed at major medical centers, and early clinical results suggest they could address several current limitations, including the blooming artifact problem with heavily calcified arteries and the difficulty of evaluating small coronary stents. These systems are not yet widely available, but they are likely to become the standard platform for cardiac CT over the coming decade.